Long intergenic non-protein coding RNA 1618 (LINC01618)

Long intergenic non-protein coding RNA 1618 (LINC01618) is a human long intergenic non-coding RNA (lincRNA), a specific subclass of long non-coding RNAs (lncRNAs) defined by their length (>200 nucleotides) and by not overlapping with coding genic regions[1][5][7]. LincRNAs such as LINC01618 are transcribed autonomously and are thought to regulate gene expression at multiple levels, including chromatin remodeling, transcriptional control, and stabilization of RNA transcripts[1][3]. While many lincRNAs are biologically relevant and some function as disease biomarkers or modulators in cancer and other diseases, the specific molecular and clinical functions of LINC01618 remain poorly characterized in the published literature. There are currently no known approved drugs targeting LINC01618, nor established biomarkers or safety concerns directly associated with it. LINC01618 is generally classified as RNA, not as a therapeutic target such as a receptor, enzyme, transporter, or transcription factor.

Other names

LINC01618